These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34336728)

  • 1. Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular Carcinoma.
    Villalobos A; Wagstaff W; Guo M; Zhang J; Bercu Z; Whitmore MJ; Cristescu MM; Majdalany BS; Wedd J; Akce M; Magliocca J; Kokabi N
    Can J Gastroenterol Hepatol; 2021; 2021():9926704. PubMed ID: 34336728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation.
    Ettorre GM; Levi Sandri GB; Laurenzi A; Colasanti M; Meniconi RL; Lionetti R; Santoro R; Lepiane P; Sciuto R; Pizzi G; Cianni R; Golfieri R; D'Offizi G; Pellicelli AM; Antonini M; Vennarecci G
    World J Surg; 2017 Jan; 41(1):241-249. PubMed ID: 27495316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Transplantation Following Yttrium-90 Radioembolization: 15-Year Experience in 207-Patient Cohort.
    Gabr A; Kulik L; Mouli S; Riaz A; Ali R; Desai K; Mora RA; Ganger D; Maddur H; Flamm S; Boike J; Moore C; Thornburg B; Alasadi A; Baker T; Borja-Cacho D; Katariya N; Ladner DP; Caicedo JC; Lewandowski RJ; Salem R
    Hepatology; 2021 Mar; 73(3):998-1010. PubMed ID: 32416631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trans-arterial radio-embolization: a new chance for patients with hepatocellular cancer to access liver transplantation, a world review.
    Levi Sandri GB; Ettorre GM; Giannelli V; Colasanti M; Sciuto R; Pizzi G; Cianni R; D'Offizi G; Antonini M; Vennarecci G; Lucatelli P
    Transl Gastroenterol Hepatol; 2017; 2():98. PubMed ID: 29264436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yttrium-90 Radioembolization for BCLC Stage C Hepatocellular Carcinoma Comparing Child-Pugh A Versus B7 Patients: Are the Outcomes Equivalent?
    Zu Q; Schenning RC; Jahangiri Y; Tomozawa Y; Kolbeck KJ; Kaufman JA; Al-Hakim R; Naugler WE; Nabavizadeh N; Kardosh A; Billingsley KG; Mayo SC; Orloff SL; Enestvedt KK; Maynard E; Ahn J; Lhewa D; Farsad K
    Cardiovasc Intervent Radiol; 2020 May; 43(5):721-731. PubMed ID: 32140840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
    Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
    World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma with macrovascular invasion treated with yttrium-90 radioembolization prior to transplantation.
    Levi Sandri GB; Ettorre GM; Colasanti M; De Werra E; Mascianà G; Ferraro D; Tortorelli G; Sciuto R; Lucatelli P; Pizzi G; Visco-Comandini U; Vennarecci G
    Hepatobiliary Surg Nutr; 2017 Feb; 6(1):44-48. PubMed ID: 28261594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
    Salem R; Gordon AC; Mouli S; Hickey R; Kallini J; Gabr A; Mulcahy MF; Baker T; Abecassis M; Miller FH; Yaghmai V; Sato K; Desai K; Thornburg B; Benson AB; Rademaker A; Ganger D; Kulik L; Lewandowski RJ
    Gastroenterology; 2016 Dec; 151(6):1155-1163.e2. PubMed ID: 27575820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of yttrium-90 microsphere radioembolization of hepatocellular carcinoma as downstaging and bridge before liver transplantation: a case report.
    Khalaf H; Alsuhaibani H; Al-Sugair A; Al-Mana H; Al-Mutawa A; Al-Kadhi Y; Al-Sebayel M
    Transplant Proc; 2010 Apr; 42(3):994-8. PubMed ID: 20430224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of survival according to kinetic changes of cytokines and hepatitis status following radioembolization with yttrium-90 microspheres.
    Liu CA; Lee IC; Lee RC; Chen JL; Chao Y; Hou MC; Huang YH
    J Formos Med Assoc; 2021 Apr; 120(4):1127-1136. PubMed ID: 32978044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioembolization Super Survivors: Extended Survival in Non-operative Hepatocellular Carcinoma.
    Gordon AC; Gabr A; Riaz A; Uddin OM; Abouchaleh N; Ali R; Kallini J; Salem R; Lewandowski RJ
    Cardiovasc Intervent Radiol; 2018 Oct; 41(10):1557-1565. PubMed ID: 29948005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating and downstaging hepatocellular carcinoma in the caudate lobe with yttrium-90 radioembolization.
    Ibrahim SM; Kulik L; Baker T; Ryu RK; Mulcahy MF; Abecassis M; Salem R; Lewandowski RJ
    Cardiovasc Intervent Radiol; 2012 Oct; 35(5):1094-101. PubMed ID: 22069121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yttrium-90 Radioembolization: Current Indications and Outcomes.
    Hamad A; Aziz H; Kamel IR; Diaz DA; Pawlik TM
    J Gastrointest Surg; 2023 Mar; 27(3):604-614. PubMed ID: 36547759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.
    Salem R; Lewandowski RJ; Mulcahy MF; Riaz A; Ryu RK; Ibrahim S; Atassi B; Baker T; Gates V; Miller FH; Sato KT; Wang E; Gupta R; Benson AB; Newman SB; Omary RA; Abecassis M; Kulik L
    Gastroenterology; 2010 Jan; 138(1):52-64. PubMed ID: 19766639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of Use of Y90 as a Bridge to Liver Resection and Transplantation in Hepatocellular Carcinoma.
    Qadan M; Fong ZV; Delman AM; Gabr A; Salem R; Shah SA
    J Gastrointest Surg; 2021 Oct; 25(10):2690-2699. PubMed ID: 34345997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient Selection and Clinical Outcomes of Y90 in Hepatocellular Carcinoma.
    Wehrenberg-Klee E; Gandhi RT; Ganguli S
    Tech Vasc Interv Radiol; 2019 Jun; 22(2):70-73. PubMed ID: 31079713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Successful Downstaging of Hepatocellular Carcinoma Outside Milan Criteria.
    Murali AR; Romero-Marrero C; Miller C; Aucejo F; Levitin A; Gill A; McLennan G; Karuppasamy K; Zein NN; Lopez R; Menon KV
    Transplantation; 2016 Nov; 100(11):2391-2397. PubMed ID: 27780187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can volumetric ADC measurement help predict response to Y90 radioembolization in HCC?
    Vouche M; Salem R; Lewandowski RJ; Miller FH
    Abdom Imaging; 2015 Aug; 40(6):1471-80. PubMed ID: 25412868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience.
    Tohme S; Sukato D; Chen HW; Amesur N; Zajko AB; Humar A; Geller DA; Marsh JW; Tsung A
    J Vasc Interv Radiol; 2013 Nov; 24(11):1632-8. PubMed ID: 24160821
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Abouchaleh N; Gabr A; Ali R; Al Asadi A; Mora RA; Kallini JR; Mouli S; Riaz A; Lewandowski RJ; Salem R
    J Nucl Med; 2018 Jul; 59(7):1042-1048. PubMed ID: 29217739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.